Compare CNVS & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNVS | XLO |
|---|---|---|
| Founded | 2000 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.4M | 56.9M |
| IPO Year | 2016 | 2021 |
| Metric | CNVS | XLO |
|---|---|---|
| Price | $2.69 | $9.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $9.00 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 110.0K | 17.2K |
| Earning Date | 02-17-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $65,733,000.00 | $43,766,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $84.42 | $168.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 589.88 |
| 52 Week Low | $1.77 | $0.46 |
| 52 Week High | $5.43 | $9.90 |
| Indicator | CNVS | XLO |
|---|---|---|
| Relative Strength Index (RSI) | 48.87 | 61.27 |
| Support Level | $2.33 | $7.47 |
| Resistance Level | $3.37 | $9.75 |
| Average True Range (ATR) | 0.19 | 0.42 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 47.88 | 62.98 |
Cineverse Corp is a technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, and audio podcasts, Podcast, Media services, and Other non-recurring. Its brands include Hallmark, ITV, Nelvana, ZDF, Konami, NFL, and Highlander.
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.